VEGFA and sarcopenia: As shown in Figure 3, serum VEGF (263.29 [207.82–353.33] pg/mL vs. 280.80 [232.93–373.76] pg/mL, P < 0.001) and Ang-1 (245.61 [198.85–307.42] pg/mL vs. 88.62 [77.80–106.01] pg/mL, P = 0.022) levels were both lower in patients with sarcopenia when compared to those control subjects (Figure 3(a) and (b)).